Key Points Question For inpatients with moderate to severe depression, is repeated intravenous ketamine superior to a psychoactive placebo (midazolam) in reducing depressive symptoms? Findings In this randomized clinical trial, there was no statistically significant difference in the primary outcome, end-of-treatment Montgomery-Åsberg Depression Rating Scale score, between the ketamine and...
Relationship difficulties are a major source of anxiety in contemporary society, contributing to social withdrawal, emotional reactivity, and conflict, which in turn increase isolation and distress. Meditation has emerged as a promising strategy for managing these stressors by fostering self-awareness, resilience, and empathy. This study explores the Inner Engineering (IE) program, a...
BACKGROUND Long COVID imposes severe functional impairments and strains health systems. Web-based mind-body interventions may offer scalable support for multidisciplinary care. OBJECTIVE We assessed the feasibility and efficacy of a 3-week web-based yogic breathing and meditation program on quality of life in individuals with long COVID. METHODS : In this 6-week waitlisted, mixed-methods...